O antitumoralnim svojstvima konoplje se u zadnje vrijeme dosta priča,ali čak i medu ljudima liberalnijih stavova postoji dosta skepse. Vrlo je malo dobro dokumentiranih slučajeva, dosta toga se svodi na anegdotalne priče. Ako imate nekoga u obitelji ili prijatelja koji je obolio, teško je ljude uvjeriti u pravovremenu akciju. Možda od pomoći mogu biti medicinska , znanstveno dokazana i metodološki ispravno provedena istraživanja.
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the crosstalk between apoptosis and autophagy.
Shrivastava A, Kuzontkoski PM, Groopman J, Prasad A.
1Division of Experimental Medicine, Beth Israel Deaconess Medical Center
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
Sean D. McAllister, Rigel T. Christian, Maxx P. Horowitz, Amaia Garcia and Pierre-Yves Desprez
California Pacific Medical Center, Research Institute, San Francisco, California
Antitumorigenic Effects of Cannabinoids beyond Apoptosis
Nadine Freimuth, Robert Ramer and Burkhard Hinz
Institute of Toxicology and Pharmacology, University of Rostock, Rostock, Germany
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (Review)
Maurizio Bifulco, Chiara Laezza, Patrizia Gazzerro, Francesca Pentimalli
Dipartimento di Scienze Farmaceutiche, Università degli Studi di Salerno, 84084 Fisciano (SA), Italy. [email protected]
Cannabinoids and cancer.
Kogan NM.
Hebrew University, Pharmacy School, Department of Medicinal Chemistry and Natural Products, Israel. [email protected]
Cannabinoids in the treatment of cancer.
Alexander A, Smith PF, Rosengren RJ.
Source
Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and Metastasis
Anju Preet1,2, Zahida Qamri1,3, Mohd W Nasser3, Anil Prasad1, Konstantin Shilo3, Xianghong Zou3, Jerome E. Groopman1 and Ramesh K. Ganju1,3
Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; 2Lombardi Cancer Center, Georgetown University Medical Center, Washington, District of Columbia; and 3Department of Pathology, Ohio State University, Columbus, Ohio
----
Dosta članaka je nažalost u punom tekstu nedostupna za širu javnost. Ako netko na forumu ima ili poznaje nekoga tko ima pristup znanstvenim bazama, molim da to i iskoristi i pomogne drugima. Čak i bez punog teksta , većina sažetaka daje dovoljno informacija u svrhu upoznavanja sa materijom i lobiranja.
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the crosstalk between apoptosis and autophagy.
Shrivastava A, Kuzontkoski PM, Groopman J, Prasad A.
1Division of Experimental Medicine, Beth Israel Deaconess Medical Center
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
Sean D. McAllister, Rigel T. Christian, Maxx P. Horowitz, Amaia Garcia and Pierre-Yves Desprez
California Pacific Medical Center, Research Institute, San Francisco, California
Antitumorigenic Effects of Cannabinoids beyond Apoptosis
Nadine Freimuth, Robert Ramer and Burkhard Hinz
Institute of Toxicology and Pharmacology, University of Rostock, Rostock, Germany
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (Review)
Maurizio Bifulco, Chiara Laezza, Patrizia Gazzerro, Francesca Pentimalli
Dipartimento di Scienze Farmaceutiche, Università degli Studi di Salerno, 84084 Fisciano (SA), Italy. [email protected]
Cannabinoids and cancer.
Kogan NM.
Hebrew University, Pharmacy School, Department of Medicinal Chemistry and Natural Products, Israel. [email protected]
Cannabinoids in the treatment of cancer.
Alexander A, Smith PF, Rosengren RJ.
Source
Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and Metastasis
Anju Preet1,2, Zahida Qamri1,3, Mohd W Nasser3, Anil Prasad1, Konstantin Shilo3, Xianghong Zou3, Jerome E. Groopman1 and Ramesh K. Ganju1,3
Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; 2Lombardi Cancer Center, Georgetown University Medical Center, Washington, District of Columbia; and 3Department of Pathology, Ohio State University, Columbus, Ohio
----
Dosta članaka je nažalost u punom tekstu nedostupna za širu javnost. Ako netko na forumu ima ili poznaje nekoga tko ima pristup znanstvenim bazama, molim da to i iskoristi i pomogne drugima. Čak i bez punog teksta , većina sažetaka daje dovoljno informacija u svrhu upoznavanja sa materijom i lobiranja.